Michael Dacks

Michael Dacks

Fundador en
Type 2 Ventures Ltd.
.
49 años
Process Industries
Consumer Services
Producer Manufacturing

Perfil

Michael Dacks is the founder of Midatadin.com Ltd. (founded in 2013) and Type 2 Ventures Ltd. (founded in 2019).
He is currently the President & Chief Operating Officer at Psyence Therapeutics Corp.
(since 2020).
He previously held positions at Vertical Peak Holdings, Inc. as an Independent Director, MedReleaf Corp.
as VP-Legal & International Business Affair (2016-2018), Plena Global Holdings, Inc. as Senior Vice President-Global Affairs (2018-2019), StateHouse Holdings, Inc. as Director (2020-2021), and Psyence Group, Inc. as Chief Operating Officer (2020-2021).
Mr. Dacks received his undergraduate degree from the University of Western Ontario in 1998 and his graduate degree from Osgoode Hall Law School in 2004.

Cargos activos de Michael Dacks

EmpresasCargoInicio
Type 2 Ventures Ltd.
Fundador 01/04/2019
Psyence Therapeutics Corp.
Presidente 01/08/2020

Antiguos cargos conocidos de Michael Dacks.

EmpresasCargoFin
STATEHOUSE HOLDINGS INC. Director/Miembro de la Junta 31/12/2021
PSYENCE GROUP INC. Director de Operaciones 01/02/2021
Corporate Officer/Principal 01/07/2019
MEDRELEAF CORP Consejero General 02/09/2018
Midatadin.com Ltd.
Fundador 01/07/2016
Ver el detalle de la experiencia de Michael Dacks.

Formación de Michael Dacks.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

93

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Process Industries

Consumer Services

Consumer Services

Producer Manufacturing

Process Industries

Process Industries

Midatadin.com Ltd.

Industrial Services

Type 2 Ventures Ltd.

Psyence Therapeutics Corp.